newsfilter
← Latest News
PR Newswire·

Mirati Therapeutics Announces Pricing of Upsized Public Offering

SAN DIEGO, Aug. 8, 2023 /PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ:MRTX), a commercial stage biotechnology company, today announced the pricing of an underwritten public offering of 9,669,631 shares of its common